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The anterogradeeffectiverefractoryperiod of the ac-
cessory connection wasdeterminedbefore and after the
administrationof ouabain (0.015 mg/kg intravenously)
duringelectrophysiologicstudies in 21patients withWolff-
Parkinson-White syndrome. The mean age(± standard
deviation) was 10± 2 years (range 1 month to 31 years).
Each patienthad stopped taking allcardiacdrugs for
more than 36 hours.Determinationof theanterograde
effectiverefractoryperiod of the accessory connection
was made using theatrialexlrastimulustechnique. A
change in theanterograderefractoryperiod of theat-
The use of digitalis in patients withWolff-Parkinson-White
syndromewhoexperiencereciprocatingtachycardiacontin-
ues to becontroversial(1-3). Digitalis,however,remains
thetreatmentof choice wheninitiatingtherapy for patients
withreciprocatingtachycardiandWolff-Parkinson-White
syndromein thepediatricage group. The change in the
anterogradeeffectiverefractoryperiod of the accessory con-
nection in response toouabainhas been variable in previ-
ouslypublishedstudies(4-9).
thepurpose of this study was to assess the effect of in-
travenousouabain on the anterogradeeffectiverefractoryperiod
of the accessoryconnectionand to evaluate the response
of reentrantachycardiainduced in thelectrophysiology
laboratorybefore and after theadministrationof ouabain.
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cessory connection was definedas an increase or decrease
of greaterthan 10 ms from the value before ouabain
administration.The post-ouabainanterogradeeffective
refractoryperiod of the accessory connection increased
in 2 (9%) of the 21patients,decreased in 9 (43%) and
wasunchanged in 10(48%).This study demonstrated a de-
crease in theanterogradeeffectiverefractoryperiod of
the accessory connection of 43% of patients with Wolff-
Parkinson-Whitesyndrome after theadministrationof
ouabain.
Methods
Study patients.Electrophysiologic studies were performed in
21 patients with Wolff-Parkinson-White syndrome (13 male, 8
female), ranging in age from I month to 31 years (mean±
standard deviation 10± 2 years). Each patient presented with a
history of recurrent supraventricular tachycardia and Wolff-Par-
kinson-White syndrome. The studies were performed to: I) define
the mechanism of tachycardia, 2) localize the position of the ac-
cessory atrioventricular connection, and 3) evaluate the response
of the anterograde effective refractory period of the accessory
connection to ouabain. In addition, we evaluated the response of
tachycardia induced in the cardrac catheterization laboratory before
and after the administration of ouabain.
Electrophysiologic study.Each study was performed in the
postabsorptivestate after premedication with meperidine, 2 mg/
kg body weight, and promethazine, I mg/kg intramuscularly. All
antiarrhythmic drugs were discontinued at least 36 hours before
the study. Consent for study was obtained from each patient or
from thepatient'sparents. After sterile preparation and with local
anesthesia, either the right or left femoral vein, or both, was entered
percutaneously. All electrode catheters were placed under fluo-
roscopic control. A5 French quadripolar electrode catheter was
positioned in both the high right atrium and the right ventricular
apex. A 6 French tripolar electrode catheter was placed across the
tricuspid valve to record the low septal right atrial and His bundle
electrograms. In order to record the coronary sinus left atnal elec-
trogram, a 5 French quadripolar electrode catheter was positioned
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after percutaneous puncture of the left antecubital vein. Only(WO
electrode catheters were used in three patients (Cases I to 3)
because of their small size.
During supraventricular tachycardia or paced ventricular
rhythm. the atrial activation sequence was determined using the
most consistent surface electrocardiogram or intracardiac onset of
ventricular activation as the reference point, and the site of earliest
right atrial activation was determined by moving the high right
atrial catheter throughout the right atrium. The coronary sinus atrial
electrogram was used to determine the left atrial activation time,
and the coronary sinus catheter was moved proximally and distally
within the coronary sinus to localize precisely the position of left-
sided accessory connections. Surface electrocardiograms included
leads I, aVF and VI' Electrograms were recorded on photographic
paper at speeds of 100 to 500 mm/s. Intracardiac electrograms
were recorded at filter frequencies between 30 and 250 Hz. Stim-
ulation studies were performed using a programmable stimulator
delivering pulses of 2 ms duration at approximately twice diastolic
threshold. The method of stimulation has been describedIn detail
elsewhere (10).
Measurements before and after ouabain. The anterograde
effective refractory period of the accessory connection was deter-
mined with the atrial extrastimulus technique during sinus rhythm
using right atrial stimulation (10, II ). Eight beats of sinus rhythm
were allowed between each extrastimulus. The effective refractory
period of an accessory atrioventricular (AV) connection was de-
fined as the longest AI- 2 interval that fails to conduct with a delta
wave. After the control anterograde effective refractory period of
the accessory connection was determined, ouabain, 0.015 mg/kg,
was administered intravenously. and 30 minutes later the antero-
grade effective refractory period was again determined. In addi-
tion, we noted the ease or difficulty with which tachycardia was
induced before and after ouabain using the same pacing protocol
at the ame pacing site. Tachycardia was classified as more difficult
to induce if. after ouabain, the echo zone was narrowed compared
with the control situation, and easier to induce if the echo zone
was wider after ouabain (10).
No complication was encountered and induced tachycardia
could be terminated either by overdrive atrial or ventricular pac-
ing, or by introducing premature atrial or ventricular beats into
tachycardia.
Results
Clinical data as well as the results of the response of the
anterogradeeffectiverefractoryperiod of the accessory con-
nection to uabainare shown in Table I. We have defined
a change in thisrefractoryperiod,after theadministration
of ouabain, as an increase ordecreaseof greaterthan10
ms.
Anterograde effective refractory period. The mean of
theanterogradeeffectiverefractoryperiodofthe accessory
connectionwas 293± 84 msbeforeand 274± 78 ms after
Table I. Clinical-Electrophysiologic Correlation
Anatomic AERPAC (ms) Response of
Age Clinical Location Tachycardia
Case (yr) Sex Diagnosis of Ap Pre-ouabain Post-ouabain Change AfterOuabain
I 0.08 M NH, SVT LL 180 170 -10(0) 0
2 0.08 M NH. SVT RA 210 210 0 ~ (E)
3 0.25 M NH . SVT LP 170 170 0 0
4 1.7 F NH . SVT RA 390 310 - 80 i
5 3 M CAVC. SVT LPL 256 270 -20 No tachycardia
6 3 F NH . SVT LL 240 260 - 20 ~
7 4 M NH , SVT RAS 260 245 -15 i
8 5 M NH, SVT LL 320 310 - 10(0) ~
9 6 M NH , SVT RAPS 340 340 0 0
10 8 M NH , SVT PS 290 230 -60 ~
II 9 F LTGA , SVT LP 480 210 -20 t
12 11 M MR, SVT PS 340 270 -70 L(El
13 II F PA, SVT LP 180 180 0 No tachycardia
14 I I M NH , SVT RA 290 290 0 L
15 13 F NH, SVT PS 320 310 - 10(0) L
16 14 M NH, SVT PS 320 320 0 No tachycardia
17 15 M NH , SVT LL 490 430 -60 i
18 18 F Ebstein's. SVT PS 290 250 -40 i
19 18 F NH, SVT PS 275 240 -25 i
20 27 F MS, SVT PS 465 480 +15 No tachycardia
21 31 M NH , SVT LA 260 260 0 L(E)
AERPAC = anterogradeffectiverefractory penodofthe accessoryconnection, AP = accessory pathway.CAVC = completeamovenrncularcanal; Ebstem's=
Ebstetn'sanomaly;LA = left anterior; LL = left lateral; LP = leftposterior; LPL = leftposterolateral; LTGA = corrected transposition ofthegreatartenes: MR=
congenitalmitralregurgitation,MS = congenitalmitralstenosis,NH= normalheart; PA= pulmonaryatresia;PS = postenor septal;RA = nghtanterior,RAPS = nght
anteriorparaseptal; RAS= fightantenorseptal;SVT = supraventriculartachycardia,0 = nudifferencebefore orafterouabain. i = tachycardiaeasiertoinduce, t =
tachycardiamoredifficulttoinduce; t(E) = echoes moredifficulttoinduce.
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Table2. Anterograde Effective Refractory Period of the
Accessory Connection: Basic Cycle Length (ms)
the administrationof ouabain.The basic cycle length at
which theanterogradeffectiverefractoryperiod of the
accessoryconnectionwas obtainedis shown in Table 2.
The mean basic cycle length was 599± 155 ms before
ouabainand was 611± 196 ms afterouabain.The
anterogradeeffectiverefractoryperiodof theaccessorycon-
nectiondid notchangein 10(47.6%)of 21 patients.An
increasewas noted in two(9.4%) of thepatients,and in
nine deceasedpatients(43%) theanterogradeffectivere-
fractoryperiodof theaccessoryconnectiondecreasedafter
administrationof ouabain.
Responseof tachycardiainduction.We were able to
assess theresponseof tachycardiainductionbeforeor after
theadministrationof ouabainin each patient (Table I). In
sixpatientsit waseasierto inducetachycardiaafterouabain
in that the atrial echo zonebecamewider. In eightpatients
the tachycardiawas more difficult to induceb causethe
atrial echo zonenarrowedafter theadministrationof oua-
bain.Threepatientshad nochangein theirresponsewith
ouabain, and in the remaining four patients tachycardia could
not beinducedeitherbeforeor afterouabain.
Site of accessorypathwayand type of heartdis-
ease.Theanatomicsite of theaccessoryconnectiondefined
by atrialmappingwasleft-sidedin nine,right-sidedin five
and posteriorseptal in sevenpatients.In 15 patients we
found noevidenceof structuralheart disease at cardiac
catheterization.Congenitalheartdiseasewas present in six
Case
I
2
3
4
5
6
7
8
9
10
II
12
13
14
15
16
17
18
19
20
21
Mean
± SD
SD = standardeviatron.
Pre-ouabain
180/480
2101420
170/500
3901540
290/400
240/470
260/610
3201510
3401520
2901500
230/490
340/695
180/660
290/440
3201740
320/820
4901790
290/600
2751590
465/950
260/850
293/599
841155
Post-ouabain
170/420
210/450
170/550
3101540
270/400
260/450
2451500
310/390
3401580
230/600
210/490
2701750
180/660
290/440
310/630
32011030
430/840
2501550
240/660
48011080
260/830
274/611
781196
patients and includedcorrectedtranspositionof thegreat
arteries,Ebstein'sanomaly,congenitalmitralstenosis,pul-
monary atresia,completeAV canal defect andcongenital
mitralregurgitation.
Discussion
Role of digitalis in Wolff-Parkinson-Whitesyn-
drome.The use of digitalis astherapyin patientswith
reciprocatingtachycardiandWolff-Parkinson-Whitesyn-
drome has long beendebated.In 1935,ScherfandSchon-
brunner(12) firstdescribedthe effect ofdigitalisin the
preexcitationsyndrome.Fox et al.(I) furthersubstantiated
enhancementof preexcitationbydigitalis.The place of dig-
italis therapy in themanagementof tachycardiain adults
withWolff-Parkinson-Whitesyndromehas been asubject
ofcontroversy(3,4).The risk of a rapidventricular response
during atrial fibrillation due toan erogradeconductiondown
an enhancedaccessoryconnectionhas been welldocu-
mented and is alife-threateningsituation(2).
Digitalis has been shown topr longAV nodalconduction
time andrefractorinessand may thus alter thec aracteristics
of thepotentialreentrantcircuit sufficiently topreventthe
initiationor maintenance,or both, ofreciprocatingtachy-
cardia.In addition,digitalishas been shown tosuppress
atrialprematurebeats,thusdecreasingthe likelihoodthat
theseprematurebeats will initiateachycardia.
Unlike adults, pediatricpatientswithoutassociatedstruc-
tural heart disease rarelyd velopatrial fibrillation or flutter
(6,7) andthereforedigitalis isthoughtto carry less risk in
this group. Theoccurrenceof severe atrialfibrillationin
childrenwasdocumentedby Mehta et al. (8), whopresented
four patients aged 6 days to 12 years in whom atrial flutter,
atrialfibrillation,or both, was present with theWolff-Par-
kinson-Whitesyndrome.Theelectrocardiogramsof eachof
the four patients showed rapidventricularrates andaberrant
ventricularconductionresultingfrom anterogradeconduc-
tion down theaccessoryconnection.
Effectof digitalison anterogradeeffectiverefractory
period.Until the present study, there have been few data
availableregardingthe effect of digitalis on theanterograde
effectiverefractory period of theaccessoryconnectionin
children.Gillette (9) found in eightpatientswith Wolff-
Parkinson-Whitesyndromethatouabainshortenedthe an-
terograde ffectiverefractory period of theaccessorycon-
nection in five patients andlengthenedit inthree.In two
of the fivepatients,therefractoryperiod washortenedto
220 ms or less. In our present study 9 of 21patientshad a
decrease in theanterogradeffectiverefractoryperiodof
the accessoryconnectionafter theadministrationfouabain.
In only two patients did therefractoryperioddecreaseto
230 ms or less.However.the controlanterogradeeffective
refractory period of theaccessoryconnectionwas less than
220 ms in fourpatients.Afteradministrationof ouabainin
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these fourpatients,there was no further decrease in the
anterogradeffectiverefractoryperiod of the accessory
connection.
Tonkin et al. (13)determinedtheanterogradeeffective
refractory periodf the accessoryconnectionin 20 adult
patients usingdifferentbasic cycle lengths. They showed a
decrease of 10 to 45 ms in this period as the basic cycle
lengthdecreased.This confirmedthe findings of Wellens
and Durrer (14), whodemonstratedthat the maximal de-
crease in theanterogradeeffectiverefractoryperiod of the
accessoryconnectionwith shorteningof the basic cycle
length was 40 ms.
In the presentstudy,the basic cycle length was analyzed
before and afterouabainin the nine patients in whom a
significantdecreasein theanterogradeffective refractory
period of theaccessoryconnectionhad been defined after
theadministrationof ouabain.In two of thesepatients,the
basic cycle length was 610 and 600 ms,respectively,before
administrationfouabainand 500 and 550 ms,respectively,
after itsadministration.Ifthese two patients aredisregarded
because ofshorteningof the basic cycle length, we are left
with sevenpatientsin whom a significant decrease in the
anterogradeeffectiverefractoryperiodofthe accessory con-
nectionoccurredafter theadministrationof ouabain.
Clinical implications. There are two ways to analyze
these data. If the mean change is used for the result, the
increase andecreasewould tend to cancel each other.If
theindividualdata areanalyzed,it can be seen that there
are threeresponsesto ouabain:1) no change,2) increase in
refractoryperiod,and 3)decreasein refractoryperiod. In
order to use these data to manage a specificatient,the
individual value is needed.Thus,we chose toenumerate
the numberofpatientswho respondedin each of the three
ways. We believe the mean value will be misleading.
Because we found such great variability among patients
both in theresponseof therefractoryperiod of the accessory
connectionand inchangesin tachycardiainducibility,we
believe that eachpatientwithWolff-Parkinson-Whitesyn-
drome andreciprocatingtachycardiamust continue to be
studied and thetherapyindividualizedbased on the findings
of the study.Ifan electrophysiologystudy cannot be per-
formed, then drugsotherthan digitalis should be used for
treatment of paroxysmalsupraventriculartachycardia.Al-
though atrial flutter and fibrillation are rare in children with
Wolff-Parkinson-Whitesyndromeand anotherwisenormal
heart, if only 1 of 100 had alife-threateningevent it would
obviously be too many.
We expres,our appreciationto Dan G. McNamara,MD, Chiefof the
Section ofCardiology,for his helpIn reviewingand editing themanuscript,
and to Henry Blair and Cathy Riley Mason for experttechnicala,slstance.
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